Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial
- 31 August 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pain
- Vol. 10 (8) , 818-828
- https://doi.org/10.1016/j.jpain.2009.01.322
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic painPain, 2008
- Treatment of painful neuropathyCurrent Opinion in Neurology, 2007
- Effects of treatments for symptoms of painful diabetic neuropathy: systematic reviewBMJ, 2007
- Lacosamide: A Review of Preclinical PropertiesCNS Drug Reviews, 2007
- Treatment of Diabetic PolyneuropathyAnnals of the New York Academy of Sciences, 2006
- New perspectives on the management of diabetic peripheral neuropathic painDiabetes and Vascular Disease Research, 2006
- Calpain product of WT‐CRMP2 reduces the amount of surface NR2B NMDA receptor subunitJournal of Neurochemistry, 2006
- Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimensPAIN®, 2005
- Clinically Important Changes in Acute Pain Outcome MeasuresJournal of Pain and Symptom Management, 2003
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePAIN®, 2001